Fundraising Fox

Aaron Royston

Investor

Managing Partner at venBio Partners

San Francisco Bay Area

Writes $20M – $30M checks Β· typically $25M

About

Aaron Royston, an MD and Wharton MBA with clinical research experience, was recognized as a White House Champion of Change and helped found and guide RayzeBio to IPO and acquisition.

Invests in

BiotechHealthtech

Experience

  1. venBio PartnersManaging Partnercurrent2015 β€” presentSan Francisco Bay Area
  2. Achieve Life SciencesBoard of Directorscurrent2026 β€” presentSan Francisco, California, United States
  3. Caldera TherapeuticsBoard of Directorscurrent2025 β€” presentBoston, Massachusetts, United States
  4. Marrow TherapeuticsBoard of Directorscurrent2024 β€” presentBoston, Massachusetts, United States
  5. Attovia TherapeuticsBoard of Directorscurrent2023 β€” presentSan Francisco Bay Area
  6. Candid TherapeuticsBoard of Directors2024 β€” 2026San Diego, California, United States
  7. 35PharmaBoard of Directors2022 β€” 2026Montreal, Quebec, Canada
  8. VicebioBoard of Directors2024 β€” 2025London Area, United Kingdom
  9. Ablaze PharmaceuticalsBoard of Directors2021 β€” 2025Shanghai, China
  10. RayzeBioBoard of Directors2020 β€” 2023San Diego, California, United States
  11. Ventyx BiosciencesBoard of Directors2021 β€” 2023San Diego, California, United States
  12. Harmony BiosciencesBoard Of Directors2017 β€” 2020Greater Philadelphia
  13. Akero TherapeuticsBoard Of Directors2018 β€” 2019San Francisco Bay Area
  14. Menlo Therapeutics Inc.Board Of Directors2017 β€” 2019San Francisco Bay Area
  15. Apellis PharmaceuticalsBoard of Directors2015 β€” 2017Louisville, Kentucky, United States
  16. Vivo CapitalSenior Associate2014 β€” 2015Palo Alto, CA
  17. Bain & CompanyConsultant2013 β€” 2014San Francisco Bay Area
  18. SportaneousFounder2010 β€” 2012
  19. The Mount Sinai HospitalClinical Research Coordinator2007 β€” 2008New York City

Education

  1. The Wharton SchoolMaster of Business Administration (M.B.A.), Health/Health Care Administration/Management
  2. University of PennsylvaniaDoctor of Medicine (M.D.)
  3. Duke UniversityB.S., Biological Sciences
  4. The Bishop's School

Skills & more

Investments14Investment Banking9Lifesciences4Neuroscience7Alternative Investments1Strategic Partnerships2Portfolio Management1Informatics8Due Diligence19Private Equity9Emerging Markets4Corporate Finance3
+4 moreStart-upsLife SciencesVenture CapitalStrategic Planning

From Aaron's professional profile.

Same school

Shared employers

Also worked at Achieve Life Sciences1

Also worked at Caldera Therapeutics1

Also worked at Candid Therapeutics1

Also worked at Harmony Biosciences1

Deals Β· 6

Marea Therapeutics, Inc.Board seat

via venBio Partners Β· filed Jun 2024 Β· $160.4M raise

Rayze BioBoard seat

via venBio Partners Β· filed Nov 2020 Β· $45M raise

Harmony BiosciencesBoard seat

via venBio Partners Β· filed Aug 2019 Β· $50M raise

Akero Therapeutics, Inc.Board seat

via venBio Partners Β· filed Dec 2018 Β· $45.5M raise

Menlo TherapeuticsBoard seat

via venBio Partners Β· filed Jul 2017 Β· $50.5M raise

Impel NeuropharmaBoard seat

via venBio Partners Β· filed Dec 2016 Β· $37.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at venBio Partners

Network4

Investors connected to Aaron in public investor directories β€” a warm-intro map.